Hospital staff perspectives towards health technology assessment: data from a multidisciplinary survey

by Tal, Orna, Booch, Meirav, Bar-Yehuda, Sara
Published in Health Res Policy Syst (2019)

Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor Agonists

by Bar-Yehuda, Sara, Barer, Faina, Volfsson, Lea, Fishman, Pnina
Published 2001

Pharmacological and Therapeutic Effects of A(3) Adenosine Receptor (A(3)AR) Agonists

by Fishman, Pnina, Bar-Yehuda, Sara, Liang, Bruce T., Jacobson, Kenneth A.
Published 2011

CF101, An Agonist to the A(3) Adenosine Receptor, Enhances the Chemotherapeutic Effect of 5-Fluorouracil in a Colon Carcinoma Murine Model

by Bar-Yehuda, Sara, Madi, Lea, Silberman, Daniel, Gery, Slosman, Shkapenuk, Maya, Fishman, Pnina
Published 2005

A(3) Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect: In Vivo Studies and Molecular Mechanism of Action

by Cohen, Shira, Barer, Faina, Bar-Yehuda, Sara, IJzerman, Adriaan P., Jacobson, Kenneth A., Fishman, Pnina
Published 2014

The PI3K–NF-κB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis

by Fishman, Pnina, Bar-Yehuda, Sara, Madi, Lea, Rath-Wolfson, Lea, Ochaion, Avivit, Cohen, Shira, Baharav, Ehud
Published 2006

Putative role of the adenosine A(3) receptor in the antiproliferative action of N(6)-(2-isopentenyl)adenosine

by Blad, Clara C., von Frijtag Drabbe Künzel, Jacobien K., de Vries, Henk, Mulder-Krieger, Thea, Bar-Yehuda, Sara, Fishman, Pnina, IJzerman, Adriaan P.
Published 2011

Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101

by BAR-YEHUDA, SARA, LUGER, DROR, OCHAION, AVIVIT, COHEN, SHIRA, PATOKAA, RENANA, ZOZULYA, GALINA, SILVER, PHYLLIS B., DE MORALES, JOSE MARIA GARCIA RUIZ, CASPI, RACHEL R., FISHMAN, PNINA
Published 2011

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study

by Stemmer, Salomon M., Benjaminov, Ofer, Medalia, Gal, Ciuraru, Noab B., Silverman, Michael H., Bar-Yehuda, Sara, Fishman, Sari, Harpaz, Zivit, Farbstein, Motti, Cohen, Shira, Patoka, Renana, Singer, Barak, Kerns, William D., Fishman, Pnina
Published 2013

Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A(3 )adenosine receptor expression

by Ochaion, Avivit, Bar-Yehuda, Sara, Cohn, Shira, Del Valle, Luis, Perez-Liz, Georginia, Madi, Lea, Barer, Faina, Farbstein, Motti, Fishman-Furman, Sari, Reitblat, Tatiana, Reitblat, Alexander, Amital, Howard, Levi, Yair, Molad, Yair, Mader, Reuven, Tishler, Moshe, Langevitz, Pnina, Zabutti, Alexander, Fishman, Pnina
Published 2006

Treatment of Dry Eye Syndrome with Orally Administered CF101: Data from a Phase 2 Clinical Trial

by Avni, Isaac, Garzozi, Hanna J., Barequet, Irina S., Segev, Fanni, Varssano, David, Sartani, Gil, Chetrit, Noa, Bakshi, Erez, Zadok, David, Tomkins, Oren, Litvin, Gilad, Jacobson, Kenneth A., Fishman, Sari, Harpaz, Zivit, Farbstein, Motti, Bar Yehuda, Sara, Silverman, Michael H., Kerns, William D., Bristol, David R., Cohn, Ilan, Fishman, Pnina
Published 2010